Active Ingredient(s): Berotralstat Hydrochloride
FDA Approved: * December 3, 2020
Pharm Company: * BIOCRYST
Category: Genetic Disorders

Berotralstat, sold under the brand name Orladeyo, is a medication used to prevent attacks of hereditary angioedema (HAE) in people aged twelve years and older.[1][3][4][5][2] The most common side effects include abdominal pain, vomiting, diarrhea, back pain, and heartburn.[2] Berotralstat was approved for medical use in the United States in December 2020,[1][2]&#... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.